Human CLDN7/CEPTRL2/claudin-1 ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_001307)
Cat. No.: pGMPC000063
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human CLDN7/CEPTRL2/claudin-1 Non-Viral expression plasmid (overexpression vector) for mouse CLDN7 overexpression in unique cell transient transfection and stable cell line development.
Go to
Claudin 7/CLDN7/CLDN7/CEPTRL2 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMPC000063 |
Gene Name | CLDN7 |
Accession Number | NM_001307 |
Gene ID | 1366 |
Species | Human |
Product Type | Mammalian (Non-Viral Vector) plasmid (overexpression) |
Insert Length | 636 bp |
Gene Alias | CEPTRL2,claudin-1,CLDN-7,CPETRL2,Hs.84359 |
Fluorescent Reporter | EGFP |
Mammalian Cell Selection | Null |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | EF1 |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGCCAATTCGGGCCTGCAGTTGCTGGGCTTCTCCATGGCCCTGCTGGGCTGGGTGGGTCTGGTGGCCTGCACCGCCATCCCGCAGTGGCAGATGAGCTCCTATGCGGGTGACAACATCATCACGGCCCAGGCCATGTACAAGGGGCTGTGGATGGACTGCGTCACGCAGAGCACGGGGATGATGAGCTGCAAAATGTACGACTCGGTGCTCGCCCTGTCCGCGGCCTTGCAGGCCACTCGAGCCCTAATGGTGGTCTCCCTGGTGCTGGGCTTCCTGGCCATGTTTGTGGCCACGATGGGCATGAAGTGCACGCGCTGTGGGGGAGACGACAAAGTGAAGAAGGCCCGTATAGCCATGGGTGGAGGCATAATTTTCATCGTGGCAGGTCTTGCCGCCTTGGTAGCTTGCTCCTGGTATGGCCATCAGATTGTCACAGACTTTTATAACCCTTTGATCCCTACCAACATTAAGTATGAGTTTGGCCCTGCCATCTTTATTGGCTGGGCAGGGTCTGCCCTAGTCATCCTGGGAGGTGCACTGCTCTCCTGTTCCTGTCCTGGGAATGAGAGCAAGGCTGGGTACCGTGTACCCCGCTCTTACCCTAAGTCCAACTCTTCCAAGGAGTATGTGTGA |
ORF Protein Sequence | MANSGLQLLGFSMALLGWVGLVACTAIPQWQMSSYAGDNIITAQAMYKGLWMDCVTQSTGMMSCKMYDSVLALSAALQATRALMVVSLVLGFLAMFVATMGMKCTRCGGDDKVKKARIAMGGGIIFIVAGLAALVACSWYGHQIVTDFYNPLIPTNIKYEFGPAIFIGWAGSALVILGGALLSCSCPGNESKAGYRVPRSYPKSNSSKEYV |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-MP0286-Ab | Anti-CLD7/ CLDN7/ CEPTRL2 monoclonal antibody |
Target Antigen | GM-Tg-g-MP0286-Ag | CLDN7 VLP (virus-like particle) |
ORF Viral Vector | pGMLP000382 | Human CLDN7 Lentivirus plasmid |
ORF Viral Vector | pGMAP000040 | Human CLDN7 Adenovirus plasmid |
ORF Viral Vector | pGMAP000104 | Human CLDN7 Adenovirus plasmid |
ORF Viral Vector | pGMPC000063 | Human CLDN7 Mammalian (Non-Viral Vector) plasmid |
ORF Viral Vector | vGMLP000382 | Human CLDN7 Lentivirus particle |
ORF Viral Vector | vGMAP000040 | Human CLDN7 Adenovirus particle |
ORF Viral Vector | vGMAP000104 | Human CLDN7 Adenovirus particle |
Target information
Target ID | GM-MP0286 |
Target Name | Claudin 7/CLDN7 |
Gene Group Identifier (Target Gene ID in Homo species) |
1366 |
Gene ID |
100072960 (Equus caballus), 101096019 (Felis catus), 1366 (Homo sapiens), 489466 (Canis lupus familiaris) 512975 (Bos taurus), 53624 (Mus musculus), 65132 (Rattus norvegicus), 714647 (Macaca mulatta) |
Gene Symbols & Synonyms | CLDN7,Cldn7,CLDN-7,CEPTRL2,CPETRL2,Hs.84359,claudin-1,cld-7 |
Target Alternative Names | Claudin 7, CLDN7,Claudin-7,CLDN-7,CLDN-7,CEPTRL2,CPETRL2,Hs.84359,claudin-1 |
Uniprot Accession |
O95471,Q3B7N4,Q9Z1L1,Q9Z261
Additional SwissProt Accessions: O95471,Q3B7N4,Q9Z261,Q9Z1L1 |
Uniprot Entry Name | |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | cancer |
Disease from KEGG | Cell adhesion molecules, Tight junction, Leukocyte transendothelial migration, Pathogenic Escherichia coli infection, Hepatitis C |
Gene Ensembl | ENSECAG00000007289, ENSG00000181885, ENSCAFG00845020640, ENSBTAG00000019448, ENSMUSG00000018569, ENSMMUG00000010551 |
Target Classification | Tumor-associated antigen (TAA) |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.